This clarification notes that Novartis did not acquire Vertex for $800 million, but rather entered into a collaboration with the company in May 2000 for the same dollar amount to "discover, develop, and commercialize small molecule drugs directed at targets in the kinase protein family."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.